<DOC>
	<DOCNO>NCT00618007</DOCNO>
	<brief_summary>To determine effect PF-00734200 HbA1c type 2 diabetic subject receive metformin</brief_summary>
	<brief_title>Effect PF-00734200 Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Men woman 1880 year age poorly control Type 2 diabetes Type 1 secondary form diabetes Currently use insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>